Subject    :    Diabetes & Metabolism Journal - Volume 39(5); October 2015
Writer jiyeon
Date 2016-01-07 15:30:49 Hit 1,549
LINK URL http://e-dmj.org/src/dmj_mail_form/dmj-v39n5-eToC.html (Click 147)
 
Diabetes & Metabolism Journal (DMJ) - Open Access
 
Table of Contents Alert
Volume 39(5); October 2015
Featured Articles
Changing Clinical Characteristics according to Insulin Resistance and Insulin Secretion in Newly Diagnosed Type 2 Diabetic Patients in Korea. Diabetes Metab J 2015;39:387-94.
 
Both insulin deficiency and insulin resistance are involved in the pathogenesis of type 2 diabetes. In the present study, only 21% of drug-naive patients with type 2 diabetes had moderate to severe insulin secretory defects, whereas 59.5% exhibited insulin resistance. Within the insulin resistant group, there was a high proportion of subjects with mild secretory defects (C-peptide > 1.7 ng/mL). The patient group with both insulin resistance and insulin deficiency was the smallest in size (2.6% in men and 1.9% in women). These findings suggest that insulin resistance is more likely to be related to the pathophysiology of type 2 diabetes than insulin deficiency in Korea, recently.
 
Serum Total Bilirubin Levels Provide Additive Risk Information over the Framingham Risk Score for Identifying Asymptomatic Diabetic Patients at Higher Risk for Coronary Artery Stenosis. Diabetes Metab J 2015;39:414-23.
 
The diagnosis of coronary artery disease is often delayed in patients with type 2 diabetes due to lack of symptoms. Therefore, the early detection of coronary artery disease remains a clinical challenge. In this study, we found that serum total bilirubin level is inversely associated with obstructive CAD and provides additive risk information over the Framingham Risk Score. Serum total bilirubin may be helpful for identifying asymptomatic diabetic patients who are at a higher risk of obstructive CAD.
 
The Preventive Effects of 8 Weeks of Resistance Training on Glucose Tolerance and Muscle Fiber Type Composition in Zucker Rats. Diabetes Metab J 2015;39:424-33.
 
In the study, we investigated the therapeutic effects of resistance training on Zucker rats before and after the onset of diabetes in order to understand the importance of timing in exercise intervention. We assessed whether 8 weeks of ladder climbing for resistance training can ameliorate impaired glucose tolerance and alter muscle fiber type compositions in Zucker rats. Our results suggest that regular resistance training initiated at the onset of diabetes can improve glucose tolerance and GLUT4 expression without changing muscle morphology in Zucker rats. Thus, resistance training might serve as an adjunct therapy in diabetes.
Reviews
Clinical Care/Education
353
Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia  Parhofer KG. Diabetes Metab J. 2015 Oct;39(5):353-362.
Obesity and Metabolic Syndrome
363
Perspective of Small-Molecule AdipoR Agonist for Type 2 Diabetes and Short Life in Obesity  Okada-Iwabu M, Iwabu M, Ueki K, Yamauchi T, Kadowaki T. Diabetes Metab J. 2015 Oct;39(5):363-372.
Clinical Care/Education
373
Dipeptidyl Peptidase 4 Inhibitors and the Risk of Cardiovascular Disease in Patients with Type 2 Diabetes: A Tale of Three Studies  Son JW, Kim S. Diabetes Metab J. 2015 Oct;39(5):373-383.
Editorial
Complications
384
Role of Bilirubin in Diabetic Vascular Complications: Can Bilirubin Predict More than Just Liver Disease?  Moon JS. Diabetes Metab J. 2015 Oct;39(5):384-386.
Original Articles
Epidemiology
387
Changing Clinical Characteristics according to Insulin Resistance and Insulin Secretion in Newly Diagnosed Type 2 Diabetic Patients in Korea  Son JW, Park CY, Kim S, Lee HK, Lee YS, Insulin Resistance as Primary Pathogenesis in Newly Diagnosed, Drug Naïve Type 2 Diabetes Patients in Korea (SURPRISE) Study Group. Diabetes Metab J. 2015 Oct;39(5):387-394.
395
The Association between Hypertension Comorbidity and Microvascular Complications in Type 2 Diabetes Patients: A Nationwide Cross-Sectional Study in Thailand  Hurst C, Thinkhamrop B, Tran HT. Diabetes Metab J. 2015 Oct;39(5):395-404.
Clinical Care/Education
405
Increased Epicardial Adipose Tissue Thickness in Type 2 Diabetes Mellitus and Obesity  Song DK, Hong YS, Lee H, Oh JY, Sung YA, Kim Y. Diabetes Metab J. 2015 Oct;39(5):405-413.
Complications
414
Serum Total Bilirubin Levels Provide Additive Risk Information over the Framingham Risk Score for Identifying Asymptomatic Diabetic Patients at Higher Risk for Coronary Artery Stenosis  Leem J, Koh EH, Jang JE, Woo CY, Oh JS, Lee MJ, Kang JW, Lim TH, Jung CH, Lee WJ, Park JY, Lee KU. Diabetes Metab J. 2015 Oct;39(5):414-423.
Pathophysiology
424
The Preventive Effects of 8 Weeks of Resistance Training on Glucose Tolerance and Muscle Fiber Type Composition in Zucker Rats  Kim JY, Choi MJ, So B, Kim HJ, Seong JK, Song W. Diabetes Metab J. 2015 Oct;39(5):424-433.
Brief Reports
Epidemiology
434
Relationship between Biological Markers, Metabolic Components, Lifestyles, and Impaired Fasting Glucose in Male Workers  Kawada T. Diabetes Metab J. 2015 Oct;39(5):434-438.
Genetics
439
Identification of Two Cases of Ciliopathy-Associated Diabetes and Their Mutation Analysis Using Whole Exome Sequencing  Kim MK, Kwak SH, Kang S, Jung HS, Cho YM, Kim SY, Park KS. Diabetes Metab J. 2015 Oct;39(5):439-443.
Letter
 
444
Letter: Predictive Factors for Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2015;39:342-7)  Kim YA. Diabetes Metab J. 2015 Oct;39(5):444-445.
Response
 
446
Response: Predictive Factors for Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2015;39:342-7)  Yagi S, Aihara KI, Sata M. Diabetes Metab J. 2015 Oct;39(5):446-447.
Erratum
 
448
Erratum: Figure Correction: Probiotics as Complementary Treatment for Metabolic Disorders  Le Barz M, Anhê FF, Varin TV, Desjardins Y, Levy E, Roy D, Urdaci MC, Marette A. Diabetes Metab J. 2015 Oct;39(5):448-449.
 
Open Access DMJ is an open access journal distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. It is indexed in PubMed, PubMed Central, SCOPUS, EMBASE, EBSCO, DOI/CrossRef, Google Scholar, KoreaMed, KoMCI, and KoreaMed Synapse.
Manuscript Submission Manuscripts should be submitted via an online manuscript-submission system of the Korean Diabetes Association (http://e-dmj.org, or http://submit.e-dmj.org).

DMJ Newsletters
No. Subject Date Hit ↓
Notice : Diabetes & Metabolism Journal - Volume 41(3); June 2017 Diabetes & Metabolism Journal - Volume 41(3); June 2017 2017-07-11 802
Notice : Diabetes & Metabolism Journal - Volume 41(2); April 2017 Diabetes & Metabolism Journal - Volume 41(2); April 2017 2017-06-29 423
Notice : Diabetes & Metabolism Journal - Volume 41(1); February 2017 Diabetes & Metabolism Journal - Volume 41(1); February 2017 2017-03-29 983
Notice : Diabetes & Metabolism Journal - Volume 40(6); December 2016 Diabetes & Metabolism Journal - Volume 40(6); December 2016 2017-01-02 1,200
23 Diabetes & Metabolism Journal - Volume 40(5); October 2016 2017-01-02 912
22 Diabetes & Metabolism Journal - Volume 40(4); August 2016 2016-09-07 1,707
21 Diabetes & Metabolism Journal - Volume 40(3); June 2016 2016-07-12 1,228
20 Diabetes & Metabolism Journal - Volume 40(2); April 2016 2016-07-05 1,507
19 Diabetes & Metabolism Journal - Volume 40(1); February 2016 2016-07-05 1,238
18 Diabetes & Metabolism Journal - Volume 39(6); December 2015 2016-01-19 1,310
17 Diabetes & Metabolism Journal - Volume 39(5); October 2015 2016-01-07 1,549
16 Diabetes & Metabolism Journal - Volume 39(4); August 2015 2016-01-07 1,630
15 Diabetes & Metabolism Journal - Volume 39(3); June 2015 2015-07-07 1,923
14 Diabetes & Metabolism Journal - Volume 39(2); April 2015 2015-05-21 1,524

목록

Gets the previous 5 pages.   Go to previous page.  [1]   2   3     Go to next page. Gets the next  5 pages.